Asensus Surgical Inc (AMEX:ASXC) has a beta value of 1.44 and has seen 1.95 million shares traded in the last trading session. The company, currently valued at $72.62M, closed the last trade at $0.27 per share which meant it -1.11% during that session. The ASXC stock price is -218.52% off its 52-week high price of $0.86 and 25.93% above the 52-week low of $0.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.22 million shares traded. The 3-month trading volume is 1.59 million shares.
Asensus Surgical Inc (AMEX:ASXC) trade information
Sporting -1.11% in the red in last session, the stock has traded in the green over the last five days, when the ASXC stock price touched $0.27 or saw a rise of 7.53%. Year-to-date, Asensus Surgical Inc shares have moved -16.27%, while the 5-day performance has seen it change 16.09%. Over the past 30 days, the shares of Asensus Surgical Inc (AMEX:ASXC) have changed -10.49%. Short interest in the company has seen 17.01 million shares shorted with days to cover at 17.6.
Asensus Surgical Inc (ASXC) estimates and forecasts
Figures show that Asensus Surgical Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 1.91% over the past 6 months, with this year growth rate of 36.67%, compared to 13.50% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 44.40% and 44.40% for the next quarter. Revenue growth from the last financial year stood is estimated to be 43.40%.
2 analysts offering their estimates for the company have set an average revenue estimate of $1.2 million for the current quarter. 2 have an estimated revenue figure of $1.28 million for the next quarter concluding in Jun 2024.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 39.50% over the past 5 years.
ASXC Dividends
Asensus Surgical Inc is expected to release its next earnings report between May 09 and May 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Asensus Surgical Inc (AMEX:ASXC)’s Major holders
Insiders own 1.97% of the company shares, while shares held by institutions stand at 9.32% with a share float percentage of 9.51%. Investors are also buoyed by the number of investors in a company, with Asensus Surgical Inc having a total of 83 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc with over 11.39 million shares worth more than $5.75 million. As of Jun 29, 2023, Vanguard Group Inc held 4.32% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 3.7 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $1.87 million and represent 1.40% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 29, 2023, the former fund manager holds about 2.93% shares in the company for having 7.73 million shares of worth $3.91 million while later fund manager owns 3.21 million shares of worth $1.62 million as of Jun 29, 2023, which makes it owner of about 1.21% of company’s outstanding stock.
